DELU SONG, MD
Retina Specialist (Ophthalmology) Physician · SAN DIEGO, CA
Individual Active NPI 1437689536
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,055 | 14,056 | $2,990,410 | $1,674,583 | $1,311,922 |
| 2023 | 1,365 | 7,396 | $1,441,345 | $790,619 | $625,680 |
| 2022 | 223 | 520 | $531,217 | $123,488 | $97,407 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 7,862 | $35 | $27 |
| 92134 | Imaging of retina | 1,501 | $44 | $32 |
| 67028 | Injection of drug into eye | 1,006 | $121 | $90 |
| J0177 | Injection, aflibercept hd, 1 mg | 937 | $331 | $264 |
| J0178 | Injection, aflibercept, 1 mg | 645 | $818 | $651 |
| 92012 | Established patient problem focused exam of visual system | 588 | $98 | $72 |
| 92014 | Established patient complete exam of visual system | 392 | $139 | $106 |
| J7999 | Compounded drug, not otherwise classified | 333 | $93 | $71 |
| 92004 | New patient complete exam of visual system | 206 | $163 | $123 |
| J2778 | Injection, ranibizumab, 0.1 mg | 166 | $158 | $125 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 91 | $16 | $12 |
| J3490 | Unclassified drugs | 44 | $2,661 | $2,110 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | ✓ | A173049 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Retina Specialist (Ophthalmology) Physician providers in California
- NPI 1801903513
- NPI 1760845184
- NPI 1033485065
- NPI 1023472560
- NPI 1003492026
- NPI 1811492952
- NPI 1295894368
- NPI 1043530777
See all Retina Specialist (Ophthalmology) Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.